US-based medical device design, development and manufacturing organization PDV MedTech has entered into a strategic partnership with Germany-based Corscience to provide medtech innovators with an end-to-end pathway from early-stage product development to manufacturing and commercialization.
The collaboration combines Corscience’s expertise in engineering complex, safety-critical medical devices with PDV MedTech’s manufacturing infrastructure across the United States and global markets. The partnership is designed to streamline product development, reduce time to market and expand access to specialized engineering and manufacturing capabilities across Europe and the United States.
The alliance aims to address key challenges in regulated medical device development, including proximity to engineering teams, access to specialized technical expertise, design for manufacturability, regulatory readiness and scalable production.
Under the agreement, European innovators will gain access to PDV MedTech’s manufacturing capabilities, while US companies will benefit from Corscience’s product development expertise and experience navigating the European Union’s Medical Device Regulation (EU MDR). Both companies also expect to expand their geographic reach by leveraging each other’s regional networks and market knowledge.
Dr. Jörg Pintaske, CEO of Corscience, said, “Expanding into the United States is a strategic priority for us, and PDV MedTech is exactly the partner we were looking for: a company with manufacturing depth, a customer-first culture, and the global infrastructure to take a product from our development labs all the way to the bedside.”
Bryant Grigsby, CEO of PDV MedTech, added, “The partnership gives medtech innovators a more complete path from early-stage development to manufacturing. It is designed to be more practical, more global, and more customer-driven. Together we are building the future of medtech, not just for our companies, but with our partners and customers.”
The partnership will offer a flexible model for companies seeking advanced development expertise in safety-critical and connected medical devices, scalable manufacturing, or a combination of both, based on product requirements, regulatory strategy, cost targets and time-to-market priorities.
Manufacturing capabilities will range from prototype and low-volume production in Morgan Hill and Utah to medium- and high-volume manufacturing in San Antonio, Texas, and global-scale production in Mexico, India and the UK, supporting the entire product lifecycle from initial prototypes to high-volume commercialization.
